Skip to main content
. 2021 Aug 14;34(1):75–81. doi: 10.4103/tcmj.tcmj_49_21

Table 2.

Correction between log-transformed angiopoietin-like protein 3 level and clinical variables

Variables Spearman’s correlation coefficient P
Age (years) −0.160 0.132
Height (cm) −0.176 0.098
Body weight (kg) −0.081 0.449
Waist circumference (cm) 0.075 0.481
BMI (kg/m2) 0.019 0.861
Systolic blood pressure (mmHg) 0.124 0.243
Diastolic blood pressure (mmHg) 0.007 0.950
Total cholesterol (mg/dL) 0.111 0.296
Log-triglyceride (mg/dL) 0.258 0.014*
HDL-C (mg/dL) −0.230 0.030*
LDL-C (mg/dL) 0.226 0.032*
Log-glucose (mg/dL) 0.088 0.412
Log-BUN (mg/dL) 0.037 0.728
Log-creatinine (mg/dL) 0.020 0.853
eGFR (mL/min) −0.054 0.612
Log-CRP (mg/dL) 0.082 0.442
Log-insulin (uIU/mL) 0.049 0.649
Log-HOMA-IR 0.078 0.465
Female, n (%) 0.227 0.031*
Hypertension, n (%) 0.115 0.281
Diabetes, n (%) 0.148 0.163

*P<0.05 was considered statistically significant (two-tailed). Data of triglyceride, glucose, blood urea nitrogen, creatinine, CRP, ANGPTL3, insulin, and HOMA-IR levels showed skewed distribution, and therefore were log-transformed before analysis. HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol, BUN: Blood urea nitrogen, eGFR: Estimated glomerular filtration rate, CRP: C-reactive protein, HOMA-IR: Homeostasis model assessment of insulin resistance, ANGPTL3: Angiopoietin-like protein 3, ACE: Angiotensin-converting enzyme, ARB: Angiotensin-receptor blocker, CCB: Calcium-channel blocker, BMI: Body mass index